Business & Regulation

Brexit: As UK politicians debate the merits of the Prime Minister’s Withdrawal Agreement, we debate its potential impact for pharma...

Oscars of science, drug shortage reporting requirements, and a new gene therapy... What’s new for pharma in business?

The business of making biopharmaceuticals is expensive – so the more data you have to back up decisions, the better.

Eva discovers that Gene's project management skills leave a lot to be desired...

A new gene therapy, a procurement process gone wrong, and backing away from a biosimilar…

The FDA’s Janet Woodcock explains how manufacturing will change in the coming years.

Recognizing and celebrating the efforts of both male and female scientists.

Are people born to lead or can they be cultivated?

Analytical bioassay cell banks certainly have benefits. But it can be difficult to know what best practices to follow.

Including pregnant women in research isn’t as difficult as some might think…